Table 1.
Summary of patient demographic data of first COVID-19 cases in the eastern region of the province of Ontario, Canada.
| Sample ID | Age | Sex | Sample collection date | GISAID accession number | Lineagea | Countries with high lineage prevalence | Reported travel history or contact with known case |
|---|---|---|---|---|---|---|---|
| 1 | 70 s | F | Mar 18 | EPI_ISL_459866 | B.1.1 (GR) | UK, USA, Portugal | Europe—Portugal |
| 2 | 40 s | M | Mar 22 | EPI_ISL_459867 | B.1 (GH) | USA, UK, Australia | North America—Barbados |
| 4 | 50 s | F | Mar 24 | EPI_ISL_459868 | B.1 (GH) | USA, UK, Australia | Contact sample 16 |
| 10 | 20 s | F | Mar 26 | EPI_ISL_459869 | B.1.5 (G) | UK, Spain, USA | Europe—Ireland |
| 11 | 40 s | F | Mar 26 | EPI_ISL_459871 | B.1.114 (GH) | Canada, USA | Contact out of province |
| 12 | 70 s | M | Mar 26 | EPI_ISL_459872 | B.1.1 (GR) | UK, USA, Portugal | Europe—Spain |
| 16 | 60 s | M | Mar 26 | EPI_ISL_459873 | B.1 (GH) | USA, UK, Australia | Contact Sample 4 |
| 17 | 50 s | F | Mar 27 | EPI_ISL_459874 | B.1 (GH) | USA, UK, Australia | |
| 18 | 20 s | M | Mar 27 | EPI_ISL_459875 | B.1.111 (GH) | Colombia, UK, USA | |
| 19 | 70 s | M | Mar 27 | EPI_ISL_459877 | B.1.5 (G) | UK, Spain, USA | |
| 21 | 80 s | M | Mar 27 | EPI_ISL_459878 | A.1 (S) | USA, Australia, Canada | |
| 23 | 20 s | F | Mar 28 | EPI_ISL_459879 | A.1 (S) | USA, Australia, Canada | |
| 24 | 50 s | M | Mar 28 | EPI_ISL_459880 | B.1 (GH) | USA, UK, Australia | Contact samples 25, 26 |
| 25 | 50 s | F | Mar 28 | EPI_ISL_459881 | B.1 (GH) | USA, UK, Australia | Contact samples 24, 26 |
| 26 | 20 s | M | Mar 28 | EPI_ISL_459882 | B.1 (GH) | USA, UK, Australia | Contact Samples 24, 25 |
| 29 | 60 s | M | Mar 28 | EPI_ISL_459883 | B.1 (GH) | USA, UK, Australia | No travel |
| 30 | 80 s | F | Mar 28 | EPI_ISL_459884 | B.1 (GH) | USA, UK, Australia | |
| 34 | 80 s | M | Mar 29 | EPI_ISL_459885 | B.1 (GH) | USA, UK, Australia | USA—Florida |
| 35 | 70 s | M | Mar 30 | EPI_ISL_459886 | B.1 (GH) | USA, UK, Australia | |
| 36 | 40 s | F | Mar 30 | EPI_ISL_459887 | B.1.3 (GH) | USA, Israel | |
| 37 | 70 s | M | Mar 30 | EPI_ISL_459888 | B.1 (GH) | USA, UK, Australia | |
| 38 | 20 s | F | Mar 30 | EPI_ISL_459889 | B.1 (GH) | USA, UK, Australia | No travel, contact |
| 39 | 60 s | M | Mar 29 | EPI_ISL_459890 | B.1 (GH) | USA, UK, Australia | USA—Florida |
| 40b | 70 s | M | Mar 30 | EPI_ISL_529029 | |||
| 41 | 70 s | M | Mar 30 | EPI_ISL_459891 | B.1.2 (GH) | USA, Australia, Canada | USA—Arizona |
| 42 | 60 s | F | Mar 30 | EPI_ISL_459892 | B.1 (GH) | USA, UK, Australia | No travel, contact |
| 49 | 50 s | F | Mar 30 | EPI_ISL_529030 | B.1 (GH) | USA, UK, Australia |
Reported data includes anonymized sample ID, age (rounded to the decade), biological sex of the participant, date of sample collection, GISAID accession number for consensus sequence, PANGOLIN lineage (GISAID Clade)a, area of the world that have high prevalence of that viral lineage, and source of infection based on patient’s reported travel or contact history.
aLineages assigned by Pangolin COVID-29 Lineage Assigner at https://pangolin.cog-uk.io/.
bLineage not assigned due to low read coverage around position 14,408, a variant characteristic of B-lineage viruses.